Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
This research aims to create and analyze a national multicenter database of patients in Italy affected by hypoparathyroidism or pseudohypoparathyroidism, two rare endocrine diseases affecting calcium regulation. The studys purpose is to collect detailed medical, genetic, diagnostic, clinical, and treatment data from a large number of patients to better understand these conditions, their prevalence, incidence, and clinical features. This observational study does not involve interventions but focuses on gathering valuable information to improve patient care and knowledge over time. The study will involve 41 specialist clinical centers across Italy, including endocrinology and pediatric departments, collecting data from patients of any age and gender diagnosed with chronic hypoparathyroidism or pseudohypoparathyroidism. Data collection will be both retrospective and prospective, spanning 10 years from the initial recruitment visit and continuing through regular follow-up visits as part of routine clinical care. No new treatments or additional procedures beyond standard care are part of this observational study. Participants will have their health information collected anonymously, including medical history, bone health assessments, genetic testing results, biochemical measures, treatment responses, and quality of life questionnaires. Researchers will analyze these data to assess disease prevalence, clinical characteristics, bone fragility, and therapy outcomes. The study emphasizes long-term follow-up with continuous data updates during routine medical visits, aiming to enhance understanding and management of these rare diseases over a decade.
Actively Recruiting
Researchers are creating and managing a national multicenter database in Italy to study patients with parathyroid carcinoma or atypical parathyroid adenoma, two very rare types of parathyroid gland cancers. The study aims to collect and analyze detailed clinical, genetic, diagnostic, histological, and therapeutic data from a wide number of patients across 33 specialist centers throughout Italy. This observational research seeks to improve understanding of these rare tumors and guide better clinical and therapeutic management. The study involves two patient groups those with parathyroid carcinoma and those with atypical parathyroid adenoma, including both sporadic and genetic forms of the diseases. Data will be collected both retrospectively from medical records and prospectively during routine follow-up visits over a 10-year period. Treatments such as surgery and medications are those conventionally used for these conditions, with no additional interventions or visits required by the study. Participants will have their medical history, diagnostic tests, biochemical and genetic data, treatments, and follow-up outcomes recorded anonymously in the database. Researchers will assess disease prevalence, tumor characteristics, and responses to therapy over short and long terms. The study spans approximately 10 years, during which ongoing clinical data is gathered to refine medical knowledge and improve patient care for these rare parathyroid cancers.
Actively Recruiting
Researchers are studying how diets supplemented with polyunsaturated fatty acids PUFAs from animal or plant sources affect chronic inflammation linked to cardiovascular risk. The study focuses on people over 55 with moderate to high cardiovascular risk but without established cardiovascular disease. It aims to better understand how these dietary changes influence a lipid and inflammation-related risk score and improve overall cardiovascular prevention by addressing chronic inflammation. Participants are randomly assigned to one of three diets fish oil supplementation providing omega-3 fatty acids DHA and EPA, camelina oil supplementation rich in alpha-linolenic acid ALA plus vitamin E, or a regular non-enriched diet with vitamin E. The study product is taken daily for 12 weeks, with doses standardized to ensure comparable vitamin E intake. The supplementation is administered before meals, and all products are provided by the study team. During the study, participants undergo a baseline clinical visit with blood sampling, heart rate, blood pressure, and waist circumference measurements, and complete a dietary questionnaire. After 12 weeks, these assessments are repeated along with monitoring diet tolerance and any clinical events. Blood samples are stored and analyzed centrally to evaluate changes in lipid and inflammatory biomarkers. The study plans to enroll 324 participants, with outcomes measured primarily by changes in a lipidomicinflammation-based risk score over 12 weeks.